SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-24-036763
Filing Date
2024-03-20
Accepted
2024-03-20 17:02:03
Documents
5
Effectiveness Date
2024-03-20

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm248328d1_s8.htm S-8 38547
2 EXHIBIT 5.1 tm248328d1_ex5-1.htm EX-5.1 53567
3 EXHIBIT 23.1 tm248328d1_ex23-1.htm EX-23.1 3326
4 EX-FILING FEES tm248328d1_ex-filingfees.htm EX-FILING FEES 20093
5 GRAPHIC tm248328d1_ex5-1img001.jpg GRAPHIC 8115
  Complete submission text file 0001104659-24-036763.txt   128174
Mailing Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF
Business Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF 44 (0) 1865 818808
Barinthus Biotherapeutics plc. (Filer) CIK: 0001828185 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-278111 | Film No.: 24768465
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)